Constitutive activation of the NFκB pathway plays an important role in the proliferation/survival of activated B cell (ABC, currently non-GCB) DLBCL (36), in which the contribution of the CK1α and CBM complex has been reported (19, 20, 37). Here, CSNK1A1 is linked to diffuse large B-cell lymphoma.